federal_register: 03-25343

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
03-25343 Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in the New Animal Drug Regulations; Drug Efficacy Study Implementation; Notice of Opportunity for Hearing; Correction Notice The Food and Drug Administration (FDA) is correcting a notice of opportunity for hearing that published in the Federal Register on August 8, 2003 (68 FR 47332). FDA is correcting a product name used by the current sponsor of NADA 141-137, the FR citation for a Drug Efficacy Study Implementation Program finding of effectiveness, and the column headings of six tables. These corrections are being made to improve the accuracy of the Federal Register. This notice also extends the deadline for parties who have requested a hearing to submit data and analysis upon which their request for a hearing relies. Other interested persons may submit comments on the notice of opportunity for hearing (NOOH) before the deadline. 2003-10-07 2003 10 https://www.federalregister.gov/documents/2003/10/07/03-25343/certain-antibiotic-new-animal-drug-products-and-use-combinations-subject-to-listings-in-the-new https://www.govinfo.gov/content/pkg/FR-2003-10-07/pdf/03-25343.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is correcting a notice of opportunity for hearing that published in the Federal Register on August 8, 2003 (68 FR 47332). FDA is correcting a product name used by the current sponsor of NADA 141-137, the FR...  

Links from other tables